Earkart Limited
Earkart Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.(Source : 202509 Prospectus Page No: 20)
- Market Cap ₹ 302 Cr.
- Current Price ₹ 219
- High / Low ₹ 266 / 136
- Stock P/E 43.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 45.1 %
- ROE 41.8 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%
Cons
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE SME IPO
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 5.66 | 28.42 | 30.80 | 42.75 | |
| 5.52 | 26.79 | 27.22 | 32.96 | |
| Operating Profit | 0.14 | 1.63 | 3.58 | 9.79 |
| OPM % | 2.47% | 5.74% | 11.62% | 22.90% |
| 0.04 | 0.05 | 0.21 | 0.09 | |
| Interest | 0.01 | 0.08 | 0.36 | 0.44 |
| Depreciation | 0.06 | 0.15 | 0.19 | 0.42 |
| Profit before tax | 0.11 | 1.45 | 3.24 | 9.02 |
| Tax % | 0.00% | 9.66% | 5.86% | 23.61% |
| 0.11 | 1.31 | 3.06 | 6.88 | |
| EPS in Rs | 22.00 | 262.00 | 612.00 | 6.59 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 96% |
| TTM: | 39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 297% |
| TTM: | 125% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 10.44 |
| Reserves | 4.72 | 6.49 | 12.97 | 9.48 |
| 0.27 | 1.23 | 4.02 | 4.96 | |
| 0.91 | 6.96 | 2.21 | 5.41 | |
| Total Liabilities | 5.95 | 14.73 | 19.25 | 30.29 |
| 0.22 | 0.25 | 1.06 | 1.17 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.46 | 0.10 | 0.19 | 0.83 |
| 4.27 | 14.38 | 18.00 | 28.29 | |
| Total Assets | 5.95 | 14.73 | 19.25 | 30.29 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -2.83 | -0.30 | -1.00 | 0.71 | |
| -1.78 | 0.40 | -1.29 | -1.32 | |
| 4.68 | 0.41 | 3.08 | -0.41 | |
| Net Cash Flow | 0.07 | 0.51 | 0.80 | -1.01 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 104.47 | 60.36 | 75.13 | 158.55 |
| Inventory Days | 138.26 | 100.90 | 113.12 | 95.52 |
| Days Payable | 92.17 | 107.33 | 19.28 | 44.04 |
| Cash Conversion Cycle | 150.56 | 53.93 | 168.97 | 210.03 |
| Working Capital Days | 192.17 | 61.90 | 111.40 | 140.19 |
| ROCE % | 23.89% | 29.02% | 45.13% |
Documents
Announcements
-
Clarification On Price Movement At Stock Exchange - Earkart Limited (544549)
2d - Informs BSE on 24-Oct-2025 no undisclosed price-sensitive information; market-driven movement.
-
Clarification sought from Earkart Ltd
17 Oct - Exchange has sought clarification from Earkart Ltd on October 17, 2025, with reference to significant movement in price, in order to ensure that investors have …
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 3 Oct
- Listing of Equity Shares of Earkart Ltd 3 Oct
Annual reports
No data available.
Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.